Formycon Gets UK Nod For Eylea Biosimilar

Teva-Partnered Ahzantive Version Of Aflibercept Receives MHRA Approval

Formycon has another UK ophthalmic biosimilar approval (Shutterstock)

More from Biosimilars

More from Business